Clinical trial
Phase II Fixed Dose Rate Gemcitabine for Advanced or Metastatic Colorectal…
NCT00220155 · Royal Marsden NHS Foundation Trust, Other · Completed
Key facts
| NCT number | NCT00220155 |
|---|---|
| Title | Phase II Fixed Dose Rate Gemcitabine for Advanced or Metastatic Colorectal Cancer |
| Official title | A Phase II Trial of Fixed Dose Rate Gemcitabine in Patients With Advanced or Metastatic Colorectal Cancer. |
| Lead sponsor | Royal Marsden NHS Foundation Trust, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | Gemcitabine |
| Enrollment | 16 |
| Start date | May 1, 2004 |
| First posted | Sep 22, 2005 |
| Last update posted | Dec 16, 2009 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: